postoperative aspiration pneumonia among adults using glp-1 receptor agonists Perioperative management of patients taking glucagon-like peptide-1 agonists: a restrictive fasting regimen is not necessary. Comment on Br J Anaesth 2025; 135: 48–78 GLP-1 Receptor Agonists And Aspiration
Description
Discover what current research and FDA findings reveal about mental health risks with semaglutide, tirzepatide, and other GLP-1 medications for diabetes and weight management.
Allulose &
GLP-1 levels correlate with disease severity
Results At 1 year, patients achieved significant weight loss with a median total weight loss (%TWL) of 25.5% and a median excess weight loss (%EWL) of 66.3% compared to 16.6% and 40.8%, respectively, at treatment initiation with BMI reduction of 3.7 kg/m2
GLP-1 Weight Loss Drugs linked to rare EYE STROKE that can cause sudden blindness
